Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP7 | O15540 | 1/20 | 0.49 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | EGFR | P00533 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15447425 | 1.00 | FABP7 (0.49) | FABP7FABP5HPGDPKMNPSR1 | |
| SCHEMBL20489039 | 0.83 | FABP7 (0.43) | FABP7FABP5PKMNPSR1ALDH1A1 | |
| SCHEMBL31184747 | 0.82 | MAPT (0.56) | HPGDALDH1A1MAPTL3MBTL1HSD17B10 | |
| SCHEMBL17390980 | 0.82 | ALDH1A1 (0.60) | FABP7FABP5HPGDALDH1A1L3MBTL1 | |
| SCHEMBL17390977 | 0.82 | ALDH1A1 (0.60) | FABP7FABP5HPGDALDH1A1L3MBTL1 | |
| SCHEMBL9002126 | 0.82 | ALDH1A1 (0.60) | FABP7FABP5HPGDALDH1A1L3MBTL1 | |
| SCHEMBL17391194 | 0.82 | ALDH1A1 (0.60) | FABP7FABP5HPGDALDH1A1L3MBTL1 | |
| SCHEMBL19323426 | 0.82 | CA1 (0.63) | FABP7FABP5NPSR1ALDH1A1CA1 | |
| SCHEMBL31184719 | 0.82 | ALDH1A1 (0.54) | ALDH1A1CA1CA2 | |
| SCHEMBL34472430 | 0.82 | ALDH1A1 (0.54) | ALDH1A1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025059577-A1 | SUBSTITUTED AMINOPYRIDINE COMPOUNDS FOR USE AS AKT1 INHIBITORS | ATAVISTIK BIO, INC. (US) | 2025-03-20 | — | — | WO | disclosed |
| EP-2417128-A2 | 6-(3-AZA-BICYCLOÝ3.1.0¨HEX-3-YL)-2-PHENYL-PYRIMIDINES | Actelion Pharmaceuticals Ltd. (CH) | 2012-02-15 | — | — | EP | disclosed |
| WO-2010116328-A2 | 6-(3-AZA-BICYCLO[3.1.0]HEX-3-YL)-2-PHENYL-PYRIMIDINES | ACTELION PHARMACEUTICALS LTD (CH) | 2010-10-14 | — | — | WO | disclosed |